L Sheppard

1.1k total citations
15 papers, 887 citations indexed

About

L Sheppard is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, L Sheppard has authored 15 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in L Sheppard's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). L Sheppard is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). L Sheppard collaborates with scholars based in United Kingdom. L Sheppard's co-authors include George J. Kontoghiorghes, A. V. Hoffbrand, M. A. Aldouri, John Goddard, A Bartlett, P. Nortey, Joseph Barr, B. Wonke, F. N. Al‐Refaie and Kontoghiorghes Gj and has published in prestigious journals such as The Lancet, Tetrahedron and Clinical Pharmacology & Therapeutics.

In The Last Decade

L Sheppard

15 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Sheppard United Kingdom 13 587 527 235 174 108 15 887
Annita Kolnagou Cyprus 23 577 1.0× 627 1.2× 125 0.5× 327 1.9× 75 0.7× 30 1.2k
ER Huehns United Kingdom 12 274 0.5× 218 0.4× 105 0.4× 76 0.4× 58 0.5× 17 558
H. C. Heinrich Germany 19 280 0.5× 447 0.8× 55 0.2× 271 1.6× 55 0.5× 107 1.1k
Jan Wiegand United States 19 437 0.7× 427 0.8× 67 0.3× 217 1.2× 164 1.5× 44 922
Ding Yong Liu United Kingdom 7 166 0.3× 208 0.4× 25 0.1× 122 0.7× 40 0.4× 7 367
J Wiegand United States 11 150 0.3× 180 0.3× 34 0.1× 55 0.3× 146 1.4× 18 493
Suzanne Hauffe Switzerland 9 142 0.2× 137 0.3× 38 0.2× 30 0.2× 159 1.5× 12 405
J.V. Princiotto United States 11 88 0.1× 148 0.3× 21 0.1× 85 0.5× 44 0.4× 21 353
Robert C. Hider United Kingdom 10 92 0.2× 88 0.2× 21 0.1× 74 0.4× 83 0.8× 18 449
Bernhard Olgemöller Germany 20 186 0.3× 49 0.1× 184 0.8× 13 0.1× 53 0.5× 36 1.2k

Countries citing papers authored by L Sheppard

Since Specialization
Citations

This map shows the geographic impact of L Sheppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Sheppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Sheppard more than expected).

Fields of papers citing papers by L Sheppard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Sheppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Sheppard. The network helps show where L Sheppard may publish in the future.

Co-authorship network of co-authors of L Sheppard

This figure shows the co-authorship network connecting the top 25 collaborators of L Sheppard. A scholar is included among the top collaborators of L Sheppard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Sheppard. L Sheppard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Al‐Refaie, F. N., L Sheppard, P. Nortey, B. Wonke, & A. V. Hoffbrand. (1995). Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. British Journal of Haematology. 89(2). 403–408. 78 indexed citations
2.
Gj, Kontoghiorghes, et al.. (1995). Oral iron chelation therapy with deferiprone. Monitoring of biochemical, drug and iron excretion changes.. PubMed. 45(1). 65–9. 18 indexed citations
3.
Cunningham, John M., F. N. Al‐Refaie, Ann E. Hunter, L Sheppard, & A. V. Hoffbrand. (1994). Differential toxicity of α‐keto hydroxypyridine iron chelators and desferrioxamine to human haemopoietic precursors in vitro. European Journal Of Haematology. 52(3). 176–179. 19 indexed citations
4.
Kontoghiorghes, George J., Joseph Barr, P. Nortey, & L Sheppard. (1993). Selection of a new generation of orally active α‐ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. American Journal of Hematology. 42(4). 340–349. 38 indexed citations
5.
Sheppard, L & George J. Kontoghiorghes. (1991). Comparative iron binding studies of bis- and tris(3-hydroxy-2-methylpyrid-4-ones) and desferrioxamine. Inorganica Chimica Acta. 188(2). 177–183. 17 indexed citations
6.
Kontoghiorghes, George J., A Bartlett, A. V. Hoffbrand, et al.. (1990). Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) I. IRON CHELATION AND METABOLIC STUDIES. British Journal of Haematology. 76(2). 295–300. 109 indexed citations
7.
Kontoghiorghes, George J., John Goddard, A Bartlett, & L Sheppard. (1990). Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clinical Pharmacology & Therapeutics. 48(3). 255–261. 117 indexed citations
8.
Kontoghiorghes, George J., L Sheppard, & Joseph Barr. (1988). Synthetic methods and in vitro iron binding studies of the novel 1-alkyl-2-ethyl-3-hydroxypyrid-4-one iron chelators. Inorganica Chimica Acta. 152(3). 195–199. 26 indexed citations
9.
Baldwin, Jack E., Andrew K. Forrest, Soo S. Ko, & L Sheppard. (1987). Preparation of 2-exomethylene penam and penicillin-2-carboxylate systems. Journal of the Chemical Society Chemical Communications. 81–81. 7 indexed citations
10.
Gj, Kontoghiorghes, L Sheppard, & Stephen T. Chambers. (1987). New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.. PubMed. 37(10). 1099–102. 17 indexed citations
11.
Baldwin, Jack E., Jeff E. Cobb, & L Sheppard. (1987). Functionalization of the 3β-methyl group of penicillin. Tetrahedron. 43(5). 1003–1012. 5 indexed citations
12.
Sheppard, L, et al.. (1987). 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD. The Lancet. 329(8545). 1294–1295. 148 indexed citations
13.
Kontoghiorghes, George J., L Sheppard, A. V. Hoffbrand, et al.. (1987). Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.. Journal of Clinical Pathology. 40(4). 404–408. 41 indexed citations
14.
Kontoghiorghes, George J., M. A. Aldouri, A. V. Hoffbrand, et al.. (1987). Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.. BMJ. 295(6612). 1509–1512. 156 indexed citations
15.
Kontoghiorghes, George J. & L Sheppard. (1987). Simple synthesis of the potent iron chelators 1-alkyl-3-hydroxy-2-methylpyrid-4-ones. Inorganica Chimica Acta. 136(1). L11–L12. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026